Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.



Oxford consultancy inspires

Local HealthScience communications consultancy recognized in Top 1000 Companies to Inspire Britain report

Read the rest of entry »

Oxford University are seeking financial support for the FIRST UK BIOMOD Team!

Oxford University are seeking financial support for the first UK BIOMOD team. In addition to the support they have received from the university, they are seeking industry sponsorship.

Read the rest of entry »

Isansys Lifecare opens European headquarters in Brandenburg-Berlin Cluster

Oxford, UK, 7th June, 2017:  Isansys Lifecare, the leader in new generation wireless patient monitoring systems, today announces the establishment of Isansys Lifecare Europe GmbH.

Located in the Brandenburg-Berlin Cluster - Europe's largest and most diversified source of new technology and a hotspot for life sciences - the new company is now fully operational and is offering Isansys’ real-time and predictive patient data solutions to the German-speaking healthcare markets now preparing for digital reform.

The aim of the facility is to help reshape the future of healthcare across Europe for patients and healthcare professionals.

Read the rest of entry »

Immunocore Announces Compelling Single Agent IMCgp100 Clinical Data in Metastatic Uveal Melanoma at ASCO 2017 Annual Meeting

(Oxford, UK and Conshohocken, US, 5 June 2017) Immunocore Limited, the world’s leading TCR company developing biological drugs to treat cancer, infectious diseases and autoimmune diseases today announces compelling single agent clinical data from the intra-patient dose escalation Phase I clinical trial of its lead programme, IMCgp100, which was presented in a poster session at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on June 3 2017.

Read the rest of entry »

Oxford Immunotec Names Karen Koski Head of Strategy and Investor Relations

OXFORD, United Kingdom and MARLBOROUGH, Mass., June 5, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company focused on developing and commercializing proprietary tests for the management of underserved immune-regulated conditions, today announced the appointment of Karen Koski as Head of Strategy and Investor Relations. The newly created position will report directly to Oxford Immunotec’s Chief Executive Officer, Dr. Peter Wrighton-Smith. Ms. Koski will join the company on June 21, 2017.

Read the rest of entry »

Immunocore Highlights IMCgp100 clinical data in Uveal Melanoma at ASCO 2017 Annual Meeting

(Oxford, UK and Conshohocken, US, 1 June 2017) Immunocore Limited, the world’s leading TCR company developing biological drugs to treat cancer, infectious diseases and autoimmune diseases, today announces that new clinical data from a second Phase I study of its lead programme, IMCgp100, will be presented in a poster session at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on 3 June 2017.

 

Read the rest of entry »

Rainbow Seed Fund & University of Birmingham Back Promising Technology Spinout Linear Diagnostics

Spinout developing novel hand-held reader tohelp in the fight against antibiotic resistance

Read the rest of entry »

BeamLine Diagnostics’ closes a £650k investment round

Beamline Diagnostics, developers of an innovative biopsy triaging system, founded by Dr. Liberty Foreman and Dr. Katherine Willetts, has closed a £650k investment round which was led by a syndicate of Angels in MedCity (AiMC) and other investors.

Read the rest of entry »

Wickham Laboratories Announces Upcoming Webinar on In-Vitro Alternatives

We would like to invite you to our latest webinar, “The Push for In-Vitro Alternatives in Toxicology: Understanding the Process Behind Developing Alternative Safety Testing”, which will take place on 29th June at 3PM London / 10 AM New York.

Read the rest of entry »

Innovate UK launch investment accelerator pilot programme

Innovate UK launch pilot programme in which UK businesses can apply for a share of £8.5m to fund feasibility studies in infrastructure systems or health and life sciences. This pilot programme for Innovate UK provides simultaneous grant funding and venture capital investment for early stage projects led by UK companies. Up to £3m of grant funding and £1.25m of private equity investment is available for projects related to infrastructure systems. This includes ‘smart’ infrastructure, energy, urban living and connected transport. Up to £3m of grant funding and £1.25m of private equity investment is available for projects related to health and life sciences. This includes health, agriculture and biosciences. Innovate UK expect projects to have total costs of up to £150,000. The programme will provide 100% of project costs. Projects should last between 3 and 12 months. The competition is open to single SMEs who are looking for early stage grant fundi ...

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

Future Blends are looking for an OBN member company who could help them strip solvent from one of their process streams. Initially looking at a 1 tonne scale. If you can help, or know of someone who might be able to then please contact Shane O’Leary at Future Blends. soleary@futureblends.com.

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us, team@obn.org.uk, and we will post.